Last updated on November 2017

A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder


Brief description of study

A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder

Detailed Study Description

Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder

Clinical Study Identifier: TX11117

Contact Investigators or Research Sites near you

Start Over

Jay Dobson

Northwest Clinical Research Center
Bellevue, WA USA

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.